Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)
Sign Up to like & getrecommendations! Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-0896-3
Abstract: Immunotherapy is a major breakthrough in cancer management [1]. Currently, immunotherapy with either autologous T cells engineered to express a chimeric antigen receptor (CAR) or with T-cell-engaging bispecific antibody designed to link CD3+ T-cells and… read more here.
Keywords: cytokine adsorption; cytokine release; crs; release syndrome ... See more keywords